23 filings
8-K
THRX
Theseus Pharmaceuticals Inc
14 Feb 24
Completion of Acquisition or Disposition of Assets
10:44am
8-K
THRX
Theseus Pharmaceuticals Inc
22 Dec 23
Entry into a Material Definitive Agreement
6:36am
8-K
THRX
Theseus Pharmaceuticals Inc
4 Dec 23
Departure of Directors or Certain Officers
6:30am
8-K
THRX
Theseus Pharmaceuticals Inc
27 Nov 23
Other Events
6:37am
8-K
THRX
Theseus Pharmaceuticals Inc
13 Nov 23
Theseus Pharmaceuticals Announces Process to Explore Strategic Alternatives
4:06pm
8-K
5jodslyy1vmbqx
31 Oct 23
Termination of a Material Definitive Agreement
4:13pm
8-K
w1m73 l6c
10 Aug 23
Theseus Pharmaceuticals Announces Business Highlights and Reports Second Quarter 2023 Financial Results
7:05am
8-K
4a0ly
13 Jul 23
Theseus Pharmaceuticals to Discontinue Enrollment in Phase 1/2 Study and Terminate Development of THE-630 in Patients with GIST
4:08pm
8-K
w1lhboxqc14pq
9 Jun 23
Submission of Matters to a Vote of Security Holders
4:32pm
8-K
4u7kf1t mvfjeu8m
25 May 23
Theseus Pharmaceuticals Reports Initial Dose Escalation Data from Ongoing Phase 1/2 Trial of THE-630 in Patients with Advanced GIST
5:04pm
8-K
1be1ov3zfn8e3
11 May 23
Theseus Pharmaceuticals Announces Business Highlights and Reports First Quarter 2023 Financial Results
7:09am
8-K
svthtkmtx h7txwhx
9 Mar 23
Theseus Pharmaceuticals Announces Business Highlights and Reports Fourth
7:00am
8-K
z2pn31tlj2jrx0fs0
5 Jan 23
Results of Operations and Financial Condition
7:02am
8-K
i6zr9a7wfnn497jr6
3 Nov 22
Theseus Pharmaceuticals Announces Business and Pipeline Highlights and Reports Third
7:00am
8-K
752g9
19 Oct 22
Theseus Pharmaceuticals Appoints Steven Stein, M.D. to Board of Directors
7:15am
8-K
fszkw
11 Aug 22
Theseus Pharmaceuticals Announces Business and Pipeline Highlights and Reports Second
7:15am
8-K
vc7iqqjshn
13 Jun 22
Submission of Matters to a Vote of Security Holders
4:39pm
8-K
c9l2y
18 May 22
Theseus Pharmaceuticals Appoints Donald Hayden to Board of Directors
4:22pm
8-K
obmx74v70tr 7a0cqr
12 May 22
Theseus Pharmaceuticals Announces Business Highlights and Reports First Quarter 2022 Financial Results
7:15am
8-K
0vp5r4msidtfc6kf8p5
10 Mar 22
Theseus Pharmaceuticals Announces Business Highlights and Reports Fourth Quarter and Full Year 2021 Financial Results
7:15am